nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—DRD4—Gilles de la Tourette syndrome	0.284	0.342	CbGaD
Pramipexole—DRD3—Gilles de la Tourette syndrome	0.245	0.295	CbGaD
Pramipexole—DRD2—Gilles de la Tourette syndrome	0.169	0.204	CbGaD
Pramipexole—HTR2A—Gilles de la Tourette syndrome	0.131	0.158	CbGaD
Pramipexole—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00285	0.0771	CbGeAlD
Pramipexole—DRD4—brain—Gilles de la Tourette syndrome	0.0014	0.038	CbGeAlD
Pramipexole—DRD3—nervous system—Gilles de la Tourette syndrome	0.00129	0.035	CbGeAlD
Pramipexole—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00124	0.0337	CbGeAlD
Pramipexole—DRD5—nervous system—Gilles de la Tourette syndrome	0.00121	0.0328	CbGeAlD
Pramipexole—DRD5—central nervous system—Gilles de la Tourette syndrome	0.00116	0.0315	CbGeAlD
Pramipexole—DRD1—midbrain—Gilles de la Tourette syndrome	0.00112	0.0305	CbGeAlD
Pramipexole—DRD3—brain—Gilles de la Tourette syndrome	0.000986	0.0267	CbGeAlD
Pramipexole—DRD5—brain—Gilles de la Tourette syndrome	0.000924	0.025	CbGeAlD
Pramipexole—DRD1—nervous system—Gilles de la Tourette syndrome	0.000924	0.025	CbGeAlD
Pramipexole—HTR1B—midbrain—Gilles de la Tourette syndrome	0.00091	0.0247	CbGeAlD
Pramipexole—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000889	0.0241	CbGeAlD
Pramipexole—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000881	0.0239	CbGeAlD
Pramipexole—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000873	0.0237	CbGeAlD
Pramipexole—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000748	0.0203	CbGeAlD
Pramipexole—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000735	0.0199	CbGeAlD
Pramipexole—SLC22A1—nervous system—Gilles de la Tourette syndrome	0.000731	0.0198	CbGeAlD
Pramipexole—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000725	0.0196	CbGeAlD
Pramipexole—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000721	0.0195	CbGeAlD
Pramipexole—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000718	0.0195	CbGeAlD
Pramipexole—DRD1—brain—Gilles de la Tourette syndrome	0.000706	0.0191	CbGeAlD
Pramipexole—SLC22A1—central nervous system—Gilles de la Tourette syndrome	0.000704	0.0191	CbGeAlD
Pramipexole—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000698	0.0189	CbGeAlD
Pramipexole—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000691	0.0187	CbGeAlD
Pramipexole—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000674	0.0183	CbGeAlD
Pramipexole—DRD2—midbrain—Gilles de la Tourette syndrome	0.000664	0.018	CbGeAlD
Pramipexole—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000649	0.0176	CbGeAlD
Pramipexole—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000645	0.0175	CbGeAlD
Pramipexole—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000604	0.0164	CbGeAlD
Pramipexole—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000582	0.0158	CbGeAlD
Pramipexole—HTR1B—brain—Gilles de la Tourette syndrome	0.000572	0.0155	CbGeAlD
Pramipexole—SLC22A1—brain—Gilles de la Tourette syndrome	0.000559	0.0152	CbGeAlD
Pramipexole—HTR1D—brain—Gilles de la Tourette syndrome	0.000554	0.015	CbGeAlD
Pramipexole—HTR2C—brain—Gilles de la Tourette syndrome	0.000549	0.0149	CbGeAlD
Pramipexole—DRD2—nervous system—Gilles de la Tourette syndrome	0.000546	0.0148	CbGeAlD
Pramipexole—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000531	0.0144	CbGeAlD
Pramipexole—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000525	0.0142	CbGeAlD
Pramipexole—HTR2B—brain—Gilles de la Tourette syndrome	0.000515	0.014	CbGeAlD
Pramipexole—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000515	0.014	CbGeAlD
Pramipexole—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000511	0.0138	CbGeAlD
Pramipexole—HTR1A—brain—Gilles de la Tourette syndrome	0.000462	0.0125	CbGeAlD
Pramipexole—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000438	0.0119	CbGeAlD
Pramipexole—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000423	0.0115	CbGeAlD
Pramipexole—DRD2—brain—Gilles de la Tourette syndrome	0.000417	0.0113	CbGeAlD
Pramipexole—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000408	0.011	CbGeAlD
Pramipexole—ADRA2C—brain—Gilles de la Tourette syndrome	0.000406	0.011	CbGeAlD
Pramipexole—HTR2A—nervous system—Gilles de la Tourette syndrome	0.00036	0.00976	CbGeAlD
Pramipexole—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000347	0.00939	CbGeAlD
Pramipexole—ADRA2A—brain—Gilles de la Tourette syndrome	0.000324	0.00877	CbGeAlD
Pramipexole—HTR2A—brain—Gilles de la Tourette syndrome	0.000275	0.00746	CbGeAlD
Pramipexole—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	8.15e-05	0.000607	CbGpPWpGaD
Pramipexole—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	8.11e-05	0.000604	CbGpPWpGaD
Pramipexole—HTR2C—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	8.08e-05	0.000602	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.98e-05	0.000594	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.97e-05	0.000594	CbGpPWpGaD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.95e-05	0.000593	CbGpPWpGaD
Pramipexole—SLC22A1—Neuronal System—SLC6A3—Gilles de la Tourette syndrome	7.94e-05	0.000592	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.84e-05	0.000584	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	7.79e-05	0.00058	CbGpPWpGaD
Pramipexole—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	7.74e-05	0.000577	CbGpPWpGaD
Pramipexole—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.74e-05	0.000577	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.74e-05	0.000577	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.68e-05	0.000572	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.68e-05	0.000572	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.64e-05	0.000569	CbGpPWpGaD
Pramipexole—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	7.59e-05	0.000566	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	7.56e-05	0.000564	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.55e-05	0.000563	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	7.52e-05	0.00056	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.45e-05	0.000556	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	7.43e-05	0.000554	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	7.34e-05	0.000547	CbGpPWpGaD
Pramipexole—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.3e-05	0.000544	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.3e-05	0.000544	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.24e-05	0.000539	CbGpPWpGaD
Pramipexole—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	7.23e-05	0.000538	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	7.21e-05	0.000537	CbGpPWpGaD
Pramipexole—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.21e-05	0.000537	CbGpPWpGaD
Pramipexole—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	7.2e-05	0.000537	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	7.2e-05	0.000537	CbGpPWpGaD
Pramipexole—DRD5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	7.17e-05	0.000534	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	7.12e-05	0.000531	CbGpPWpGaD
Pramipexole—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	7.06e-05	0.000526	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	7.04e-05	0.000525	CbGpPWpGaD
Pramipexole—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.95e-05	0.000518	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.8e-05	0.000507	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.71e-05	0.0005	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.7e-05	0.000499	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	6.67e-05	0.000497	CbGpPWpGaD
Pramipexole—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.63e-05	0.000494	CbGpPWpGaD
Pramipexole—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.63e-05	0.000494	CbGpPWpGaD
Pramipexole—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.5e-05	0.000485	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.5e-05	0.000485	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.48e-05	0.000483	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.47e-05	0.000482	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.43e-05	0.000479	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.4e-05	0.000477	CbGpPWpGaD
Pramipexole—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.28e-05	0.000468	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.28e-05	0.000468	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.26e-05	0.000466	CbGpPWpGaD
Pramipexole—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.25e-05	0.000466	CbGpPWpGaD
Pramipexole—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.24e-05	0.000465	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.24e-05	0.000465	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	6.21e-05	0.000463	CbGpPWpGaD
Pramipexole—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.17e-05	0.00046	CbGpPWpGaD
Pramipexole—SLC22A2—Metabolism—HDC—Gilles de la Tourette syndrome	6.17e-05	0.00046	CbGpPWpGaD
Pramipexole—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.07e-05	0.000453	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.07e-05	0.000453	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	6.06e-05	0.000451	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.04e-05	0.00045	CbGpPWpGaD
Pramipexole—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	6e-05	0.000447	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.85e-05	0.000436	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.82e-05	0.000434	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.81e-05	0.000433	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.78e-05	0.000431	CbGpPWpGaD
Pramipexole—SLC22A1—Metabolism—HDC—Gilles de la Tourette syndrome	5.75e-05	0.000428	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.68e-05	0.000423	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.66e-05	0.000422	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.64e-05	0.00042	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.59e-05	0.000416	CbGpPWpGaD
Pramipexole—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.57e-05	0.000415	CbGpPWpGaD
Pramipexole—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.51e-05	0.000411	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.51e-05	0.000411	CbGpPWpGaD
Pramipexole—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.49e-05	0.000409	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.42e-05	0.000404	CbGpPWpGaD
Pramipexole—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.38e-05	0.000401	CbGpPWpGaD
Pramipexole—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.38e-05	0.000401	CbGpPWpGaD
Pramipexole—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.35e-05	0.000399	CbGpPWpGaD
Pramipexole—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.29e-05	0.000394	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	5.25e-05	0.000391	CbGpPWpGaD
Pramipexole—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.2e-05	0.000388	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.08e-05	0.000379	CbGpPWpGaD
Pramipexole—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.05e-05	0.000376	CbGpPWpGaD
Pramipexole—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.05e-05	0.000376	CbGpPWpGaD
Pramipexole—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.93e-05	0.000368	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.93e-05	0.000368	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.9e-05	0.000365	CbGpPWpGaD
Pramipexole—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.87e-05	0.000363	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.8e-05	0.000357	CbGpPWpGaD
Pramipexole—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.76e-05	0.000355	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.76e-05	0.000354	CbGpPWpGaD
Pramipexole—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.72e-05	0.000352	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.72e-05	0.000352	CbGpPWpGaD
Pramipexole—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.7e-05	0.00035	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.66e-05	0.000347	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.6e-05	0.000343	CbGpPWpGaD
Pramipexole—SLC22A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.58e-05	0.000341	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.51e-05	0.000336	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.45e-05	0.000332	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.43e-05	0.00033	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.37e-05	0.000326	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.36e-05	0.000325	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.34e-05	0.000323	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.32e-05	0.000322	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.29e-05	0.000319	CbGpPWpGaD
Pramipexole—SLC22A1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	4.27e-05	0.000318	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.27e-05	0.000318	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.25e-05	0.000317	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.24e-05	0.000316	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.23e-05	0.000315	CbGpPWpGaD
Pramipexole—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.23e-05	0.000315	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.13e-05	0.000307	CbGpPWpGaD
Pramipexole—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.1e-05	0.000305	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.09e-05	0.000305	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.07e-05	0.000304	CbGpPWpGaD
Pramipexole—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.07e-05	0.000304	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.07e-05	0.000303	CbGpPWpGaD
Pramipexole—DRD5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.05e-05	0.000302	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.02e-05	0.0003	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.97e-05	0.000296	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.96e-05	0.000295	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.94e-05	0.000294	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.88e-05	0.000289	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.86e-05	0.000288	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.84e-05	0.000286	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.79e-05	0.000283	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.79e-05	0.000282	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.75e-05	0.000279	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.7e-05	0.000276	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.7e-05	0.000275	CbGpPWpGaD
Pramipexole—DRD5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.68e-05	0.000274	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.67e-05	0.000274	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.65e-05	0.000272	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.64e-05	0.000271	CbGpPWpGaD
Pramipexole—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.6e-05	0.000268	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.55e-05	0.000264	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.54e-05	0.000263	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.53e-05	0.000263	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.49e-05	0.00026	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.44e-05	0.000257	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.44e-05	0.000256	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.43e-05	0.000256	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.43e-05	0.000256	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.42e-05	0.000255	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.34e-05	0.000249	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.33e-05	0.000248	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.32e-05	0.000247	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.3e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.3e-05	0.000246	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.29e-05	0.000245	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.22e-05	0.00024	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.22e-05	0.00024	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.21e-05	0.000239	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.21e-05	0.000239	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.2e-05	0.000239	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.2e-05	0.000238	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.16e-05	0.000235	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.12e-05	0.000232	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.11e-05	0.000232	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.11e-05	0.000232	CbGpPWpGaD
Pramipexole—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.1e-05	0.000231	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.1e-05	0.000231	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.06e-05	0.000228	CbGpPWpGaD
Pramipexole—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.04e-05	0.000226	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3e-05	0.000224	CbGpPWpGaD
Pramipexole—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.99e-05	0.000223	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.99e-05	0.000222	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.91e-05	0.000217	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.9e-05	0.000216	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.87e-05	0.000214	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.87e-05	0.000214	CbGpPWpGaD
Pramipexole—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.85e-05	0.000213	CbGpPWpGaD
Pramipexole—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.85e-05	0.000213	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.83e-05	0.000211	CbGpPWpGaD
Pramipexole—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.82e-05	0.00021	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.79e-05	0.000208	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.78e-05	0.000207	CbGpPWpGaD
Pramipexole—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.76e-05	0.000206	CbGpPWpGaD
Pramipexole—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.71e-05	0.000202	CbGpPWpGaD
Pramipexole—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000201	CbGpPWpGaD
Pramipexole—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.66e-05	0.000198	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.63e-05	0.000196	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.61e-05	0.000194	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.6e-05	0.000194	CbGpPWpGaD
Pramipexole—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.59e-05	0.000193	CbGpPWpGaD
Pramipexole—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.59e-05	0.000193	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.57e-05	0.000192	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.55e-05	0.00019	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.53e-05	0.000189	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.53e-05	0.000189	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.5e-05	0.000186	CbGpPWpGaD
Pramipexole—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.44e-05	0.000182	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.42e-05	0.00018	CbGpPWpGaD
Pramipexole—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.41e-05	0.00018	CbGpPWpGaD
Pramipexole—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.4e-05	0.000179	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.38e-05	0.000177	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.36e-05	0.000176	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.35e-05	0.000175	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.33e-05	0.000173	CbGpPWpGaD
Pramipexole—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.31e-05	0.000172	CbGpPWpGaD
Pramipexole—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.3e-05	0.000172	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.29e-05	0.000171	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.28e-05	0.00017	CbGpPWpGaD
Pramipexole—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.24e-05	0.000167	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.21e-05	0.000165	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.19e-05	0.000163	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.18e-05	0.000163	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.18e-05	0.000162	CbGpPWpGaD
Pramipexole—DRD5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000162	CbGpPWpGaD
Pramipexole—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.000157	CbGpPWpGaD
Pramipexole—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.09e-05	0.000156	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.06e-05	0.000154	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.03e-05	0.000152	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.000152	CbGpPWpGaD
Pramipexole—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.03e-05	0.000151	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.03e-05	0.000151	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.97e-05	0.000147	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.96e-05	0.000146	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.95e-05	0.000145	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.9e-05	0.000142	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.9e-05	0.000141	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.89e-05	0.000141	CbGpPWpGaD
Pramipexole—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.85e-05	0.000138	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.84e-05	0.000137	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.84e-05	0.000137	CbGpPWpGaD
Pramipexole—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.82e-05	0.000136	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.77e-05	0.000132	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.76e-05	0.000131	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.72e-05	0.000128	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.72e-05	0.000128	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.69e-05	0.000126	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.67e-05	0.000125	CbGpPWpGaD
Pramipexole—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.66e-05	0.000124	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.65e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.64e-05	0.000123	CbGpPWpGaD
Pramipexole—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.63e-05	0.000121	CbGpPWpGaD
Pramipexole—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.6e-05	0.00012	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.54e-05	0.000115	CbGpPWpGaD
Pramipexole—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.53e-05	0.000114	CbGpPWpGaD
Pramipexole—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.53e-05	0.000114	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.5e-05	0.000111	CbGpPWpGaD
Pramipexole—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.44e-05	0.000108	CbGpPWpGaD
Pramipexole—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.42e-05	0.000106	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.39e-05	0.000104	CbGpPWpGaD
Pramipexole—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.29e-05	9.58e-05	CbGpPWpGaD
Pramipexole—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.24e-05	9.25e-05	CbGpPWpGaD
Pramipexole—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.24e-05	9.2e-05	CbGpPWpGaD
Pramipexole—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.2e-05	8.95e-05	CbGpPWpGaD
Pramipexole—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.09e-05	8.12e-05	CbGpPWpGaD
Pramipexole—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.76e-06	7.27e-05	CbGpPWpGaD
